JPM

243.43

-0.51%↓

AXP

264.87

-0.95%↓

RY

117.78

+0.12%↑

MMC

219.19

+0.08%↑

TD

62.13

-0.08%↓

JPM

243.43

-0.51%↓

AXP

264.87

-0.95%↓

RY

117.78

+0.12%↑

MMC

219.19

+0.08%↑

TD

62.13

-0.08%↓

JPM

243.43

-0.51%↓

AXP

264.87

-0.95%↓

RY

117.78

+0.12%↑

MMC

219.19

+0.08%↑

TD

62.13

-0.08%↓

JPM

243.43

-0.51%↓

AXP

264.87

-0.95%↓

RY

117.78

+0.12%↑

MMC

219.19

+0.08%↑

TD

62.13

-0.08%↓

JPM

243.43

-0.51%↓

AXP

264.87

-0.95%↓

RY

117.78

+0.12%↑

MMC

219.19

+0.08%↑

TD

62.13

-0.08%↓

Search

Ares Commercial Real Estate Corp

Closed

SectorFinance

3.81 0.26

Overview

Share price change

24h

Current

Min

3.76

Max

3.81

Key metrics

By Trading Economics

Income

-4.8M

-11M

Sales

23M

18M

EPS

-0.15

Dividend yield

16.67

Profit margin

-60.906

EBITDA

8.5M

3.4M

Recommendations

By TipRanks

Recommendations

Sell

12 Months Forecast

+25.59% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

16.67%

4.36%

Next Earnings

8 May 2025

Next Ex Dividend date

27 Jun 2025

Market Stats

By TradingEconomics

Market Cap

195M

Previous open

3.55

Previous close

3.81

Technical Score

By Trading Central

Confidence

Very Strong Bullish Evidence

Ares Commercial Real Estate Corp Chart

Past performance is not a reliable indicator of future results.

Related News

27 Apr 2025, 23:55 UTC

Market Talk

Oil Edges Higher Amid Hopes for Easing U.S.-China Trade Tensions -- Market Talk

27 Apr 2025, 23:47 UTC

Market Talk

Gold Falls Amid Dollar Strength, Signs of Easing U.S.-China Trade Tensions -- Market Talk

27 Apr 2025, 23:42 UTC

Market Talk

Nikkei May Rise as Fears About U.S.-China Tensions Ebb -- Market Talk

27 Apr 2025, 23:12 UTC

Earnings

Sinopharm Group 1Q Rev CNY141.66B Vs. CNY147.27B >1099.HK

27 Apr 2025, 23:12 UTC

Earnings

Sinopharm Group 1Q Net CNY1.46B Vs. Net CNY1.42B >1099.HK

27 Apr 2025, 20:41 UTC

Earnings

Pharmaron Beijing 1Q Net CNY305.58M Vs. Net CNY230.56M >300759.SZ

27 Apr 2025, 20:41 UTC

Earnings

Pharmaron Beijing: Higher Contributions From Laboratory Services Among Factors Supporting Results> 300759.SZ

27 Apr 2025, 20:41 UTC

Earnings

Pharmaron Beijing 1Q Rev CNY3.10B Vs. CNY2.67B >300759.SZ

27 Apr 2025, 18:41 UTC

Top News

Bessent Doesn't Know If Trump and Xi Have Talked on Trade -- Barrons.com

27 Apr 2025, 11:00 UTC

Top News

Wall Street's New Tariff Safe Haven: High-Tax Biotech Stocks -- Heard on the Street -- WSJ

27 Apr 2025, 05:41 UTC

Earnings

China Everbright Bank 1Q Net CNY12.46B Vs. Net CNY12.43B >601818.SH

27 Apr 2025, 05:41 UTC

Earnings

China Everbright Bank: Lower Net Interest Income Weighed on Operating Income>601818.SH

27 Apr 2025, 05:41 UTC

Earnings

China Everbright Bank 1Q Operating Income CNY33.10B Vs. CNY34.49B>601818.SH

27 Apr 2025, 05:41 UTC

Earnings

China Everbright Bank 1Q Impairment Loss on Credit Assets Was CNY8.49B; Down 15.6% on Year>601818.SH

27 Apr 2025, 05:41 UTC

Earnings

China Everbright Bank 1Q Operating Expenses Was CNY9.15B; Down 3.2%>601818.SH

27 Apr 2025, 05:41 UTC

Earnings

China Everbright Bank 1Q Net Interst Income Was CNY22.54B; Down 6.8% on Year>601818.SH

27 Apr 2025, 05:34 UTC

Earnings

Chongqing Rural Commercial Bank: 1Q Results Supported by Higher Net Interest Income>3618.HK

27 Apr 2025, 05:34 UTC

Earnings

Chongqing Rural Commercial Bank 1Q Operating Income CNY7.22B Vs. CNY7.13B>3618.HK

27 Apr 2025, 05:34 UTC

Earnings

Chongqing Rural Commercial Bank 1Q Net CNY3.75B Vs. Net CNY3.52B >3618.HK

27 Apr 2025, 05:29 UTC

Earnings

China Shenhua Energy: Results Weighed by Fall in Selling Prices of Coal >1088.HK

27 Apr 2025, 05:29 UTC

Earnings

China Shenhua Energy 1Q Net CNY13.37B Vs. Net CNY17.76B >1088.HK

27 Apr 2025, 05:29 UTC

Earnings

China Shenhua Energy 1Q Rev CNY69.59B Vs. CNY87.65B >1088.HK

27 Apr 2025, 05:29 UTC

Earnings

China Shenhua Energy: Lower Revenue From Electricity Sales Also Hurt Results >1088.HK

27 Apr 2025, 05:21 UTC

Earnings

CMOC Group 1Q Net CNY3.95B Vs. Net CNY2.07B >3993.HK

27 Apr 2025, 05:21 UTC

Earnings

CMOC Group: Cost Cuts Also Among Factors that Boosted 1Q Net >3993.HK

27 Apr 2025, 05:21 UTC

Earnings

CMOC Group 1Q Rev CNY46.01B Vs. CNY46.12B >3993.HK

27 Apr 2025, 05:21 UTC

Earnings

CMOC Group: Increase in Prices of Copper, Cobalt Supported Results>3993.HK

27 Apr 2025, 03:00 UTC

Top News

Chinese Manufacturers Are Scouring the World for New Buyers -- WSJ

27 Apr 2025, 00:30 UTC

Top News

Meta's 'Digital Companions' Will Talk Sex With Users -- Even Children -- WSJ

27 Apr 2025, 00:30 UTC

Top News

Meta's 'Digital Companions' Will Talk Sex With Users -- Even Children -- WSJ -2-

Peer Comparison

Price change

Ares Commercial Real Estate Corp Forecast

Price Target

By TipRanks

25.59% upside

12 Months Forecast

Average 4.81 USD  25.59%

High 5.5 USD

Low 3.75 USD

Based on 7 Wall Street analysts offering 12 month price targets forAres Commercial Real Estate Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Sell

7 ratings

0

Buy

5

Hold

2

Sell

Technical Score

By Trading Central

3.7644 / 3.88Support & Resistance

Short Term

Very Strong Bullish Evidence

Intermediate Term

No Evidence

Long Term

Weak Bearish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Ares Commercial Real Estate Corp

Ares Commercial Real Estate Corporation, a specialty finance company, originates and invests in commercial real estate (CRE) loans and related investments in the United States. It provides a range of financing solutions for the owners, operators, and sponsors of CRE properties. The company originates senior mortgage loans, subordinate debt and preferred equity products, mezzanine loans, and other CRE investments, including commercial mortgage-backed securities. It has elected and qualified to be taxed as a real estate investment trust for the United States federal income tax purposes under the Internal Revenue Code of 1986. Ares Commercial Real Estate Corporation was incorporated in 2011 and is based in New York, New York.